Answers are grounded in this paper and cite their sources.
In vitro susceptibility profiles of 58 Paecilomyces clinical isolates are reported. Amphotericin B, itraconazole, and echinocandins showed poor activity against Paecilomyces lilacinus, while the new triazoles were active against it. Paecilomyces variotii exhibited a different susceptibility pattern, being susceptible to most antifungal agents apart from voriconazole and ravuconazole.
No takes yet. Share an insight, caveat, or question.
Castelli et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: